Anti-ST17B/ STK17B/ DRAK2 monoclonal antibody

Anti-ST17B/ STK17B/ DRAK2 antibody for FACS & in-vivo assay

Target products collectionGo to STK17B/STK17B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1718-Ab-1/ GM-Tg-hg-MP1718-Ab-2Anti-Human STK17B monoclonal antibodyHuman
GM-Tg-rg-MP1718-Ab-1/ GM-Tg-rg-MP1718-Ab-2Anti-Rat STK17B monoclonal antibodyRat
GM-Tg-mg-MP1718-Ab-1/ GM-Tg-mg-MP1718-Ab-2Anti-Mouse STK17B monoclonal antibodyMouse
GM-Tg-cynog-MP1718-Ab-1/ GM-Tg-cynog-MP1718-Ab-2Anti-Cynomolgus/ Rhesus macaque STK17B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1718-Ab-1/ GM-Tg-felg-MP1718-Ab-2Anti-Feline STK17B monoclonal antibodyFeline
GM-Tg-cang-MP1718-Ab-1/ GM-Tg-cang-MP1718-Ab-2Anti-Canine STK17B monoclonal antibodyCanine
GM-Tg-bovg-MP1718-Ab-1/ GM-Tg-bovg-MP1718-Ab-2Anti-Bovine STK17B monoclonal antibodyBovine
GM-Tg-equg-MP1718-Ab-1/ GM-Tg-equg-MP1718-Ab-2Anti-Equine STK17B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1718-Ab-1/ GM-Tg-hg-MP1718-Ab-2; GM-Tg-rg-MP1718-Ab-1/ GM-Tg-rg-MP1718-Ab-2;
GM-Tg-mg-MP1718-Ab-1/ GM-Tg-mg-MP1718-Ab-2; GM-Tg-cynog-MP1718-Ab-1/ GM-Tg-cynog-MP1718-Ab-2;
GM-Tg-felg-MP1718-Ab-1/ GM-Tg-felg-MP1718-Ab-2; GM-Tg-cang-MP1718-Ab-1/ GM-Tg-cang-MP1718-Ab-2;
GM-Tg-bovg-MP1718-Ab-1/ GM-Tg-bovg-MP1718-Ab-2; GM-Tg-equg-MP1718-Ab-1/ GM-Tg-equg-MP1718-Ab-2
Products NameAnti-STK17B monoclonal antibody
Formatmab
Target NameSTK17B
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-STK17B benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ST17B/ STK17B/ DRAK2 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm001600mouse Stk17b Lentivirus plasmid
    ORF Viral VectorvGMLPm001600mouse Stk17b Lentivirus particle


    Target information

    Target IDGM-MP1718
    Target NameSTK17B
    Gene ID9262,98267,170904,696908,488453,101086995,511373,100054971
    Gene Symbol and Synonyms3110009A03Rik,DRAK2,STK17B
    Uniprot AccessionO94768,Q91XS8
    Uniprot Entry NameST17B_HUMAN,ST17B_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000081320
    Target ClassificationKinase

    The target: STK17B, gene name: STK17B, also named as DRAK2. Enables ATP binding activity and protein serine/threonine kinase activity. Involved in intracellular signal transduction; positive regulation of fibroblast apoptotic process; and protein phosphorylation. Located in nucleus. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.